Published on: March 13, 2026

PRISM BioLab and Receptor.AI today announced that they have entered into a drug discovery collaboration agreement to develop an integrated, AI-navigated, physics-guided platform for the discovery of orally available small molecules targeting intracellular protein–protein interactions (PPIs), membrane proteins, and complex receptor systems.

For more details, please click here.